LOLuciane Meneguin Ortega

Luciane Meneguin Ortega

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luciane Meneguin Ortega has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Entre a ciência e o mercado: desafios e possibilidades da consultoria e da pesquisa aplicada na FEA-USP

    by Lucas Eduardo Carmo Assis, Luciane Meneguin Ortega

    No Brasil, a interação entre universidades e organizações externas é estratégica para o desenvolvimento econômico e a inovação. Este artigo investiga os fatores condicionantes da oferta de consultoria e pesquisa aplicada por docentes da Faculdade de Economia, Administração, Contabilidade e Atuária da Universidade de São Paulo (FEA-USP) a organizações externas, tema estratégico, mas marcado por barreiras institucionais, culturais e operacionais. A pesquisa justifica-se pela dificuldade persistente de transformar conhecimento técnico-científico em soluções acessíveis ao setor produtivo, sobretudo nas Ciências Sociais Aplicadas. Com abordagem qualitativa e caráter exploratório, adotou-se o estudo de caso único da FEA-USP, com a realização de 40 entrevistas semiestruturadas com docentes (20,6% do total), analisadas por Análise de Conteúdo. Os resultados evidenciaram entraves como sobrecarga de trabalho, excesso de burocracia, ausência de canais institucionais ativos, uso de linguagem técnica pouco acessível e receios quanto à mercantilização do conhecimento. Por outro lado, os docentes valorizaram alternativas de aperfeiçoamento institucional, especialmente a proposição de uma plataforma digital de conexão com o mercado e o apoio de agentes de intermediação comercial, alinhados à missão pública da universidade. A pesquisa oferece um diagnóstico-propositivo e propõe uma estrutura de intermediação capaz de articular ciência, impacto e aplicabilidade, contribuindo para a academia, ao valorizar a atuação prática e sugerir mecanismos de monetização do conhecimento, e para o mercado, ao ampliar o acesso à expertise científica, reduzir custos de transação e fomentar soluções pragmáticas baseadas em evidências.

  • Open Access

    Translational science at the undergraduate level: awakening talents to overcome the valley of death - case report

    by Rui Seabra Ferreira Jr., Cristina Kampus Mantovani, Ana Silvia Sartori Barraviera Seabra Ferreira, Laura de Oliveira Nascimento, Merari de Fátima Ramires Ferrari, Daniel Fabio Kawano, Katlin Brauer Massirer, Gabriel Forato Anhê, Rosley Anholon, Celso Pereira Caricati, et al.

    Background: In the biomedical field, translational science is the process of applying basic scientific knowledge to advance clinical research through the creation of new drugs, devices, medical procedures, preventive measures, and diagnostic kits. The Covid-19 pandemic exposed a shortage of professionals trained in translational research, essential for responding to global demands. To drive advancements, researchers must overcome the ‘valley of death’, a critical phase in clinical investigation. In response, CEVAP at São Paulo State University (UNESP), Botucatu, Brazil, has developed a strong 'knowledge industry' centered on Translational Science. As part of its research and innovation efforts, CEVAP has developed two biopharmaceuticals, the fibrin sealant and the apilic antivenom, which are currently in the final stage of development. In 2024, CEVAP began the first Brazilian Contract Development and Manufacturing Organization (CDMO) for developing and producing validated and qualified pilot-scale batches to generate clinical trial material.


  • Open Access

    Translational Science at the Undergraduate Level: Awakening Talents to Overcome the Valley of Death – Viewpoint Showing a Success Case (Preprint)

    by Rui Seabra Ferreira Jr, Cristina Kampus Mantovani, Ana Silvia Sartori Barraviera Seabra Ferreira, Laura de Oliveira Nascimento, Merari de Fátima Ramires Ferrari, Daniel Fabio Kawano, Katlin Brauer Massirer, Gabriel Forato Anhê, Rosley Anholon, Celso Pereira Caricati, et al.

    BACKGROUND Background: Translational science is the process of applying basic scientific knowledge with the goal of developing clinical research by creating new medicines, devices, medical procedures, preventative measures, and diagnostic kits. These actions are known as moving “from bench to bedside.” The Covid-19 pandemic has highlighted a shortage of translational research professionals prepared to respond immediately to global demands. To achieve these advancements, investigators must overcome the challenging phase of clinical investigation commonly referred to as the “valley of death”. Conversely, The Center for the Study of Venoms and Venomous Animals (CEVAP), from São Paulo State University (UNESP), Botucatu, SP, Brazil, has built a robust “knowledge industry” focused on translational science. CEVAP offers specialized programs in diagnostic and therapeutic innovations (lato sensu) and well as graduate professional program (stricto sensu) at master's and doctoral levels. As part of its research and innovation efforts, CEVAP has developed two biopharmaceuticals, named fibrin sealant and apilic antivenom, which are currently in the final stage of development. OBJECTIVE The objectives of this project were to assess interest and begin preparing professionals from undergraduate students for the topic of translational science. METHODS In 2024, CEVAP began the first Brazilian Contract Development and Manufacturing Organization (CDMO) for developing and producing clinical trial material derived from Brazilian biodiversity. The optional undergraduate Course in Translational Science represents the final stage in the development of the “knowledge industry” and was offered to students at the three public universities in São Paulo state (USP, UNESP and UNICAMP). This course, developed in partnership with the Department of Pediatrics at the University of Oxford and the Oxford Research Group LATAM, aims to awaken talent assess students’ interest in this subject. The large number of applications demonstrated the interest of students in pursuing this modern perspective of the pharmaceutical research. RESULTS - CONCLUSIONS From this point forward, the project will evolve into a “Qualification in Translational Science” which must last at least one year and will be offered to students already enrolled in any of the courses at any of the São Paulo university courses. The preparation of these professionals will be strategic to save lives and combat future epidemics or pandemics that will emerge worldwide. CLINICALTRIAL -

  • Open Access

    Programa Empreendedorismo-Escola: influenciando a Universidade por meio do tripé ensino, pesquisa e extensão

    by Luciane Meneguin Ortega

    Programa Empreendedorismo-Escola: influenciando a Universidade por meio do tripé ensino, pesquisa e extensão